Patents Represented by Attorney Kyle D. Yesland
  • Patent number: 7335761
    Abstract: The present invention includes avian ovomucoid gene expression controlling regions which may be operably linked to one or more useful amino acid coding sequences.
    Type: Grant
    Filed: January 31, 2005
    Date of Patent: February 26, 2008
    Assignee: AviGenics, Inc.
    Inventors: Alex J. Harvey, Markley C. Leavitt, Youliang Wang
  • Patent number: 7312374
    Abstract: This invention provides methods for the stable introduction of heterologous coding sequences into the genome of a bird and expressing the coding sequences to produce desired proteins or to alter the phenotype of the bird. The present invention provides preferred methods for introducing a transgene into the cytoplasm of avian embryonic cells by cytoplasmic microinjection. The embryo then develops into a transgenic adult capable of expressing a heterologous protein and/or capable of generating a line of transgenic birds through breeding. Synthetic vectors and gene promoters useful in the methods are also provided by the present invention, as are transgenic birds that express heterologous protein and avian eggs containing heterologous protein.
    Type: Grant
    Filed: September 18, 2002
    Date of Patent: December 25, 2007
    Assignee: AviGenics, Inc
    Inventors: Jeffrey C. Rapp, Leandro Christmann
  • Patent number: 7294507
    Abstract: The present invention includes nucleic acid molecules comprising an artificial chromosome and an avian ovomucoid gene expression controlling region operably linked to the coding sequence of a useful polypeptide.
    Type: Grant
    Filed: May 28, 2004
    Date of Patent: November 13, 2007
    Assignee: AviGenics, Inc.
    Inventors: Alex J. Harvey, Markley C. Leavitt, Youliang Wang
  • Patent number: 7199279
    Abstract: The invention provides for cells containing nucleic acids which include lysozyme gene expression controlling region nucleotide sequences which typically are linked to a polynucleotide encoding a heterologous polypeptide.
    Type: Grant
    Filed: April 1, 2002
    Date of Patent: April 3, 2007
    Assignee: AviGenics, Inc.
    Inventor: Jeffrey C. Rapp
  • Patent number: 7176300
    Abstract: The invention provides for lysozyme gene expression control regions which may include a 5? matrix attachment region; an intrinsically curved region of DNA; a transcription enhancer; a negative regulatory element; at least one hormone responsive element; an avian CRI repeat element; a proximal lysozyme promoter, and can be linked to a nucleotide sequence encoding a heterologous polypeptide.
    Type: Grant
    Filed: August 3, 2001
    Date of Patent: February 13, 2007
    Assignee: AviGenics, Inc.
    Inventor: Jeffrey C. Rapp
  • Patent number: 7135562
    Abstract: A recombinant nucleic acid is provided having an avian promoter. One embodiment of the present invention contemplates the use of a gut-specific promoter, wherein a promoter can be the chicken intestinal fatty acid binding protein promoter region. A method for making a transgenic bird is also disclosed by transfecting a bird with a vector comprising a recombinant nucleic acid comprising a chicken intestinal fatty acid binding protein promoter region operably linked to a heterologous nucleic acid expressing a desired polypeptide to be expressed in the gut tissue of an avian.
    Type: Grant
    Filed: March 14, 2002
    Date of Patent: November 14, 2006
    Assignee: University of Cincinnati
    Inventors: Nelson D. Horseman, Scott L. Pratt
  • Patent number: 7129390
    Abstract: This invention provides vectors and methods for the stable introduction of exogenous nucleic acid sequences into the genome of avians in order to express the exogenous sequences to alter the phenotype of the avians or to produce desired proteins. In particular, transgenic avians are produced which express exogenous sequences in their oviducts and which deposit exogenous proteins into their eggs. Avian eggs that contain exogenous proteins are encompassed by this invention. The instant invention further provides novel forms of interferon and erythropoietin which are efficiently expressed in the oviduct of transgenic avians and deposited into avian eggs.
    Type: Grant
    Filed: January 24, 2003
    Date of Patent: October 31, 2006
    Assignees: AviGenics, Inc, University of Georgia Research Foundation, Inc.
    Inventors: Robert D. Ivarie, Alex J. Harvey, Julie A. Morris, Guodong Liu, Jeffrey C. Rapp
  • Patent number: 7122309
    Abstract: Genetic modification or selection of avians requires that large numbers of birds be genetically analyzed for sequences of interest. Typically, DNA is extracted on an individual basis from samples taken from the birds. Current methods of DNA extraction extract the DNA from blood or other tissues using tedious and time-consuming procedures. The present invention provides a high throughput screening assay for detecting a genetic sequence in multiple samples. The assay further provides a DNA extraction method that allows DNA to be extracted rapidly from multiple avian samples, such as red blood cells. The extraction method is extremely reliable and does not require that each sample be quantitated post-extraction. The extracted DNA can be used for a variety of genetic assays, including a high throughput screening assay to identify insertion of a transgene. The present invention is particularly useful for extracting DNA from nucleated RBCs.
    Type: Grant
    Filed: May 2, 2002
    Date of Patent: October 17, 2006
    Assignee: AviGenics, Inc.
    Inventor: Alex J. Harvey
  • Patent number: 7049480
    Abstract: The invention includes methods of enucleating avian eggs comprising visualizing internal structure of an avian egg utilizing TPLSM and ablating the nucleus of the egg by near-infrared light.
    Type: Grant
    Filed: September 1, 2000
    Date of Patent: May 23, 2006
    Assignee: AviGenics, Inc.
    Inventors: Leandro Christmann, Scott L. Pratt, Jeffrey C. Rapp
  • Patent number: 6875588
    Abstract: The present invention provides novel isolated nucleic acids comprising an avian nucleic acid sequence encoding an ovomucoid gene expression control region. The ovomucoid promoter region of the present invention allows expression of an operably linked heterologous nucleic acid insert in a transfected cell such as, for example, an avian oviduct cell. The isolated avian ovomucoid promoter of the present invention may be operably linked with a selected nucleic acid insert, wherein the nucleic acid insert encodes a polypeptide desired to be expressed in a transfected cell. The recombinant DNA of the present invention may further comprise a polyadenylation signal sequence. The present invention further includes expression vectors comprising an isolated avian ovomucoid gene expression control region of the present invention, and transfected cells and transgenic avians comprising the expression vectors.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: April 5, 2005
    Assignee: AviGenics, Inc.
    Inventors: Alex J. Harvey, Youliang Wang
  • Patent number: 6605577
    Abstract: This invention relates to a clear shampoo comprising a polysiloxane component and methods for making the same. In one embodiment, the polysiloxane component comprises a side chain component having a hindered amine group.
    Type: Grant
    Filed: December 17, 2001
    Date of Patent: August 12, 2003
    Assignee: Chemsil Silicones, Inc.
    Inventors: James Jeffries Harrison, Zimming Sun, James Parr, Nohemi Harrison
  • Patent number: 6586237
    Abstract: Compositions comprising two or more linear DNA molecules capable of self-replicating when circularized, the linear DNA molecules comprising a single overhanging nucleotide at each 3′ end, wherein a pair of overhanging nucleotides of a linear DNA molecule of the composition are different than a pair of overhanging nucleotides of another linear DNA molecule of the composition.
    Type: Grant
    Filed: May 24, 2002
    Date of Patent: July 1, 2003
    Inventor: Kyle David Yesland